Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: AMG 827 in Subjects With Psoriatic Arthritis [Phase 2]
Phase 2 trial of AMG 827 in psoriatic arthritis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement [Phase 3]
Phase 3 trial assessing efficacy and safety of secukinumab in active psoriatic arthritis with axial skeleton involvement has completed with …
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of brodalumab in psoriatic arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP) [Phase 4]
Phase 4 clinical trial update for a Danish population-based assessment addressing psoriasis and psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: The Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic Arthritis [NA]
A completed clinical trial investigated the effects of n-3 polyunsaturated fatty acids in patients with psoriatic arthritis, with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-21Clinical Trial Update: Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis [Phase 3]
Open-label extension study of tofacitinib in psoriatic arthritis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis [Phase 3]
Phase 3 trial update on secukinumab in active psoriatic arthritis showing efficacy at 24 weeks with long-term safety, tolerability, and effi…
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Effect of Secukinumab in the Treatment of Psoriatic Arthritis [Phase 2]
Phase 2 clinical trial update evaluating secukinumab for psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis [Phase 2]
Phase 2 trial evaluating two doses of apremilast (CC-10004) in Japanese patients with moderate-to-severe plaque-type psoriasis; study comple…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
A completed clinical trial evaluating post-marketing use of CT-P13 (infliximab) for standard care in patients with rheumatoid diseases who a…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
Clinical trial update on T cells and TNF blockade in inflammatory diseases; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: A Phase 4 Clinical Study of Brodalumab [Phase 4]
A Phase 4 clinical study of brodalumab completed, investigating psoriasis vulgaris and psoriatic arthritis (with related pustular and erythr…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 long-term efficacy and safety study of ixekizumab in active psoriatic arthritis has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)
Post-marketing observational study evaluating the impact of AbbVie's Patient Support Program on patient-reported outcomes and health resourc…
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 trial update evaluating a self-injection e-device for certolizumab pegol in several inflammatory diseases; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis [Phase 2]
Phase II study of Apremilast (CC-10004) in adults with psoriatic arthritis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial comparing tofacitinib to methotrexate for psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Psoriasis-Arthritis & Bone Program [Phase 2]
Phase 2 clinical trial update for a psoriasis-arthritis and bone program completed, investigating treatments for psoriasis and psoriatic art…
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Abatacept Bone Effects in Psoriatic Arthritis With Bone Biomarker [Phase 4]
A Phase 4 clinical trial update evaluating abatacept's effects on bone changes and bone biomarkers in patients with psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: Prospective Evaluation of the Radiographic Efficacy of Enbrel
Completed clinical trial investigating radiographic efficacy of Enbrel in rheumatoid arthritis and psoriatic arthritis; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 trial updates show 16-week efficacy and 2-year safety, tolerability, and efficacy data for secukinumab in active psoriatic arthritis…
-
CLINICAL_TRIALS trial_result · 2019-06-28Clinical Trial Update: Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial update for secukinumab in active psoriatic arthritis evaluating efficacy, structural damage inhibition, safety, and t…
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
Clinical trial update assessing the efficacy of etanercept over 12 months in routine treatment of rheumatoid arthritis and related inflammat…
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta [Phase 1]
Phase 1 postmarketing transfer study evaluating Cimzia (certolizumab pegol) from mother to infant via placenta has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis [Phase 3]
Extension study up to 3 years for secukinumab in psoriatic arthritis completed with results posted in 2019.